We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
-14.49%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+476.55%
AUM
$400B
AUM Growth
-$75.9B
Cap. Flow
+$5.41B
Cap. Flow %
1.35%
Top 10 Hldgs %
18.01%
Holding
6,980
New
409
Increased
2,565
Reduced
2,533
Closed
543

Sector Composition

Rank Sector Weight
1 Technology 15.59%
2 Healthcare 9.3%
3 Financials 8.52%
4 Consumer Discretionary 7.65%
5 Industrials 4.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DBD
5451
DELISTED
Diebold Nixdorf Incorporated
DBD
$236K ﹤0.01%
104,299
-307,193
-75% -$1.14M
RCKY icon
5452
Rocky Brands
RCKY
$380M
$235K ﹤0.01%
6,876
+871
+15% +$32.6K
SYRS
5453
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$234K ﹤0.01%
24,307
+2,647
+12% +$24.8K
FOVL
5454
DELISTED
iShares Focused Value Factor ETF
FOVL
$233K ﹤0.01%
4,765
-18,000
-79% -$973K
PRLD icon
5455
Prelude Therapeutics
PRLD
$350M
$232K ﹤0.01%
44,295
+20,205
+84% +$103K
DAPR icon
5456
FT Vest US Equity Deep Buffer ETF April
DAPR
$311M
$231K ﹤0.01%
7,918
-18,082
-70% -$548K
VTYX
5457
DELISTED
Ventyx Biosciences
VTYX
$231K ﹤0.01%
+18,868
New +$282K
RPID icon
5458
Rapid Micro Biosystems
RPID
$106M
$230K ﹤0.01%
53,490
+22,545
+73% +$105K
RSPM icon
5459
Invesco S&P 500 Equal Weight Materials ETF
RSPM
$188M
$230K ﹤0.01%
+7,410
New +$261K
ESEA icon
5460
Euroseas
ESEA
$553M
$229K ﹤0.01%
11,757
-1,304
-10% -$28.1K
SNFCA icon
5461
Security National Financial
SNFCA
$253M
$229K ﹤0.01%
32,893
-937
-3% -$6.81K
EMAN
5462
DELISTED
eMagin Corporation
EMAN
$229K ﹤0.01%
352,247
-1,569,102
-82% -$1.29M
MG icon
5463
Mistras Group
MG
$500M
$228K ﹤0.01%
38,402
-67
-0.2% -$396
HBIO icon
5464
Harvard Bioscience
HBIO
$28.5M
$227K ﹤0.01%
6,302
-3,072
-33% -$139K
ISTR icon
5465
Investar Holding Corp
ISTR
$415M
$227K ﹤0.01%
10,370
-19
-0.2% -$389
TIMB icon
5466
TIM SA
TIMB
$9.04B
$227K ﹤0.01%
18,692
+5,424
+41% +$74K
KODK icon
5467
Kodak
KODK
$828M
$226K ﹤0.01%
48,525
-82,073
-63% -$428K
LGO
5468
Largo
LGO
$62.8M
$226K ﹤0.01%
33,064
+4,837
+17% +$44K
OSPN icon
5469
OneSpan
OSPN
$588M
$225K ﹤0.01%
18,902
-123,872
-87% -$1.63M
SPRO icon
5470
Spero Therapeutics
SPRO
$66.6M
$225K ﹤0.01%
303,201
+161,775
+114% +$470K
SAGA
5471
DELISTED
Sagaliam Acquisition Corp. Class A Common Stock
SAGA
$225K ﹤0.01%
22,800
WPCB.U
5472
DELISTED
Warburg Pincus Capital Corporation I-B Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
WPCB.U
$225K ﹤0.01%
22,907
PSQ icon
5473
ProShares Short QQQ
PSQ
$745M
$224K ﹤0.01%
3,112
-2,236
-42% -$149K
ACVA icon
5474
ACV Auctions
ACVA
$1.36B
$223K ﹤0.01%
34,148
-365,357
-91% -$3.76M
FHTX icon
5475
Foghorn Therapeutics
FHTX
$271M
$223K ﹤0.01%
16,378
+3,233
+25% +$41.7K

Similar funds

Goldman Sachs's Q2 2022 Portfolio in Review

As of Q2 2022, Goldman Sachs held 6,980 positions worth $400B, down 16% from $476B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Goldman Sachs's Q2 2022 filing shows 409 new, 2,565 increased, 2,533 reduced and 543 closed positions. Its largest new stake was iShares US Treasury Bond ETF: 6,205,288 shares worth $148M. The largest sale was Invesco QQQ Trust, an estimated $993M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

  • Goldman Sachs's largest Q2 2022 buy was iShares US Treasury Bond ETF: 6,205,288 shares worth $148M.
  • Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $2.97B increase.
  • Goldman Sachs's biggest Q2 2022 reduction was Invesco QQQ Trust, cutting an estimated $993M.
  • Goldman Sachs fully exited Cerner Corp in Q2 2022, selling an estimated $863M.
  • Goldman Sachs's ten largest holdings make up 18% of its $400B portfolio in Q2 2022.
  • Goldman Sachs opened 409 new positions and closed 543 in Q2 2022.
  • Goldman Sachs's portfolio value fell 16% quarter-over-quarter to $400B.

Based on Goldman Sachs's 13F filing for Q2 2022, filed 15 Aug 2022.